Tudor Investment Corp’s Molecular Partners MOLN Stock Holding History

Tudor Investment Corp’s Portfolio MOLN Stock Details MOLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15,006	Closed	-$288K	–	2425
2021 Q4	$288K	Sell	15,006 -158,000	-91%	-$2.66M	﹤0.01%	1877
2021 Q3	$3.39M	Sell	173,006 -2,027	-1%	-$39.9K	0.06%	421
2021 Q2	$3.59M	Buy	+175,033	New	+$3.47M	0.07%	345

Other funds holding MOLN

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Tudor Investment Corp's MOLN Position: Q1 2022 in Review

Tudor Investment Corp sold out of Molecular Partners (MOLN) in Q1 2022, closing a stake of 15,006 shares — an estimated $288K sold.

Tudor Investment Corp first reported a position in MOLN in Q2 2021 and held it in 3 quarters. The position peaked at $3.59M in Q2 2021. 8 funds tracked by Wall St. Rank hold MOLN as of Q1 2022.

Tudor Investment Corp reported no remaining Molecular Partners position as of Q1 2022 after selling out during the quarter.
Tudor Investment Corp sold 15,006 Molecular Partners shares in Q1 2022, an estimated $288K.
Tudor Investment Corp first reported a position in Molecular Partners in Q2 2021 and held it in 3 quarters.
Tudor Investment Corp's Molecular Partners position peaked at $3.59M in Q2 2021.
8 funds tracked by Wall St. Rank held Molecular Partners as of Q1 2022.

Based on Tudor Investment Corp's 13F filing for Q1 2022, filed 16 May 2022.